|
Target organ
|
OD
|
SD
|
ED contribution
|
SD
|
|---|
|
(mSv/MBq)
|
(mSv/MBq)
|
|---|
|
Adrenals
|
1.11E−02
|
7.64E−04
|
9.57E−05
|
6.57E−06
|
|
Brain
|
3.23E−02
|
3.24E−03
|
3.23E−04
|
3.24E−05
|
|
Breasts
|
6.21E−03
|
5.15E−04
|
7.45E−04
|
6.18E−05
|
|
Gallbladder wall
|
1.81E−02
|
1.18E−03
|
1.56E−04
|
1.02E−05
|
|
LLI wall
|
1.15E−02
|
4.04E−04
|
6.88E−04
|
2.42E−05
|
|
Small intestine
|
1.48E−02
|
1.00E−03
|
1.27E−04
|
8.61E−06
|
|
Stomach wall
|
1.10E−02
|
6.51E−04
|
1.32E−03
|
7.81E−05
|
|
ULI wall
|
1.52E−02
|
1.15E−03
|
9.12E−04
|
6.92E−05
|
|
Heart wall
|
1.42E−02
|
2.15E−03
|
1.22E−04
|
1.85E−05
|
|
Kidneys
|
4.51E−02
|
6.50E−03
|
3.88E−04
|
5.59E−05
|
|
Liver
|
2.69E−02
|
4.78E−03
|
1.07E−03
|
1.91E−04
|
|
Lungs
|
1.39E02
|
2.00E−04
|
1.67E−03
|
2.40E−05
|
|
Muscle
|
7.77E−03
|
4.03E−04
|
6.68E−05
|
3.46E−06
|
|
Ovaries
|
1.07E−02
|
2.08E−04
|
8.53E−04
|
1.67E−05
|
|
Pancreas
|
2.24E−02
|
1.78E−03
|
1.93E−04
|
1.53E−05
|
|
Red marrow
|
1.15E−02
|
1.07E−03
|
1.38E−03
|
1.28E−04
|
|
Osteogenic cells
|
1.35E−02
|
1.21E−03
|
1.35E−04
|
1.21E−05
|
|
Skin
|
5.87E−03
|
4.13E−04
|
5.87E−05
|
4.13E−06
|
|
Spleen
|
2.01E−02
|
9.07E−04
|
1.73E−04
|
7.80E−06
|
|
Testes
|
7.70E−03
|
6.51E−05
|
–
|
–
|
|
Thymus
|
1.82E−02
|
3.27E−03
|
1.56E−04
|
2.81E−05
|
|
Thyroid
|
1.77E−02
|
8.90E−03
|
7.07E−04
|
3.56E−04
|
|
Urinary bladder wall
|
7.17E−02
|
2.63E−02
|
2.87E−03
|
1.05E−03
|
|
Uterus
|
1.28E−02
|
1.01E−03
|
1.10E−04
|
8.73E−06
|
|
Total body
|
9.39E−03
|
7.64E−04
|
–
|
–
|
|
ED (mSv/MBq)
| | |
1.43E−02
|
2.60E−04
|
|
ED (mSv/MBq) ICRP 60
| |
1.52E−02
|
5.0E−04
|
- ODs calculated for the adult male model (73.7 kg, implemented in OLINDA) based on piglet biodistribution and organ geometry data that were scaled to human circumstances
-
OD organ dose, ED effective dose (ICRP 103), SD standard deviation mean over three animals
